Latest filing published 14 Aug 2026 for Takeda Pharmaceutical Company Limited, €196k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Nicola Greenway is a declared insider of Takeda Pharmaceutical Co Ltd, with filings sourced from SEC (Form 4). The record holds 3 filings, for trades running from 13 July 2026 to 14 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 14 August 2026, reports a transaction of €196k in Takeda Pharmaceutical Co Ltd. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations